• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameDAKO HERCEPTEST
Classification Namesystem, test, her-2/neu, ihc
Generic Namedako anti-her2 ihc system
ApplicantDAKO A/S
PMA NumberP980018
Date Received05/18/1998
Decision Date09/25/1998
Product Code
MVC[ Registered Establishments with MVC ]
Docket Number 98M-0857
Notice Date 10/27/1998
Advisory Committee Pathology
Expedited Review Granted? No
Combination Product No
Recalls CDRH Recalls
Approval Order Statement 
Approval for the dako herceptest. This device is a semi-quantitative immunohistochemical assay to determine her2 overexpression in breast cancer tissues routinely processed for histological evaluation. Herceptest is indicated as an aid in the assessment of patients for whom herceptin(r)(transtuzumab) treatment is being considered.
Supplements: S001 S002 S003 S004 S005 S006 S007 S008 S009 
S010 S011 S012 S013 S014 S015 S016 S017 S018 
-
-